|
|
 |
|
Viewing report
|
|
|
|
OTC Healthcare in the Baltic States to 2011
Datamonitor, Aug 2008, Pages: 181
This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Baltic states. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.
Scope
- Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
- Provides market value, volume, expenditure and consumption data by market, segment and subsegment
- Includes company and brand share data by categories
Highlights of this title
The market for OTC Healthcare in the Baltic states increased between 2001-2006, growing at an average annual rate of 6.8%.
The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Grindeks in third place.
Key reasons to purchase this title
- Discover the major quantitative trends affecting the OTC Healthcare markets
- Understand consumers consumption and expenditure patterns
- Understand the future direction of the market with reliable historical data and full five year forecasting
Customers who bought this item also bought
OTC Healthcare in the US to 2011
OTC Healthcare in China to 2011
OTC Healthcare in Canada to 2011
OTC Healthcare in Belgium to 2011
OTC Healthcare in Thailand to 2011
OTC Healthcare in Japan to 2011
OTC Healthcare in Denmark to 2011
OTC Healthcare in Italy to 2011
OTC Healthcare in the UK to 2011
OTC Healthcare in Poland to 2011
|
|
|
|
